CIK 0001737287 · Non-accelerated filer<br>Smaller reporting company
Allogene Therapeutics, Inc.
Sign in to watch- Ticker
- ALLO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823562771
- Phone
- (650) 457-2700
- Business address
- 210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1 Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- DRS Other Draft Registration Statement
- D Other Notice of Sales of Unregistered Securities
Page 30 of 30 · 587 filings